Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Business

Dr. Martens owners to raise $1.78 billion in London IPO

2021 01 25T100951Z 2 LYNXMPEH0O0LT RTROPTP 4 DRMARTENS IPO - Global Banking | Finance

By Abhinav Ramnarayan and Tanishaa Nadkar

(Reuters) – The owners of Dr. Martens aim to raise close to 1.3 billion pounds ($1.78 billion) from a London listing of the classic British boot brand, according to a lead manager.

The company, known for its yellow stitching and chunky soles, will sell 350 million existing shares somewhere between 330 and 370 pence per share, according to a bookrunner.

This suggests a deal size of between 1.15-1.295 billion pounds and a valuation of around 3.3-3.7 billion pounds.

A second bookrunner said later that the deal was “covered” throughout the range on the full deal size; which means that investor demand has matched the targeted deal size at the top end of the price range.

Dr. Martens is one of several IPOs that have kicked off in Europe this year, as issuers look up to make up for a quiet 2020, when the spread of COVID-19 wreaked havoc on economies and dulled stock market listing volumes in Europe.

E-card retailer Moonpig is also making preparations for a London IPO, while on the continent Poland’s InPost looks set for an Amsterdam listing and AUTO1 is on track for a Frankfurt listing.

Private equity fund Permira, which bought Dr. Martens in 2014 for 380 million euros, will sell part of its stake in the IPO alongside other existing shareholders.

Goldman Sachs and Morgan Stanley are joint global co-ordinators for the offering, and Barclays, HSBC, Bank of America-Merrill Lynch and RBC Europe are joint bookrunners. Lazard is a financial adviser.

(Reporting by Tanishaa Nadkar in Bengaluru and Abhinav Ramnarayan in London; Editing by Shailesh Kuber and Louise Heavens)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post